Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Am J Prev Med. 2013 Aug;45(2):228–236. doi: 10.1016/j.amepre.2013.03.017

Table 3.

Potential research designs to evaluate the efficacy and effectiveness of mHealth interventions.

Key Points Additional Considerations
Treatment Development Stage The following quasi-experimental designs are useful during treatment development. They are also important for studies in which randomization is not possible.
Pre–post test designs17 Target measures that are collected before the intervention begins (pretest) serve as the baseline. Post-test measures are used to estimate change due to the intervention. Causality cannot be determined because there is no control or comparison group, and potential confounding variables limit interpretation of effects. Can be used with continuous measurements to examine changes in the trend of target behavior over time. Measures of potential confounding variables help estimate change due to the intervention and assess variation introduced by other factors.
n-of-1 design18 Multiple cross-over, single-subject experimental design that is an experimental variant of the pre– post text design. It reduces bias and accounts for random variation over time through repeated, short-term comparisons of treatments, where each treatment may be an active intervention or placebo. The patient receives treatments in a systematic or random sequence. n-of-1 trials are applicable to chronic symptomatic conditions and to treatments characterized by rapid onset of action and quick washout. Obviously, this design is only feasible when ethically appropriate.
Interrupted Time-Series Design Pre–post test design where large numbers of repeated measurements are collected before and after the treatment. The premise is that administration of the treatment should produce an interruption to the pre-treatment time series. The interruption can be found along any of three dimensions: form of the effect (the level, slope, variance, cyclicity); permanence of the effect (continuous or discontinuous); and immediacy of the effect. This design is especially suited to mHealth, in which multiple measurements are common.
Mature Intervention Testing When interventions have been developed that are feasible and usable and have quasi-experimental or pilot data supporting their efficacy, larger randomized trials are appropriate.
RCT The participants, groups or locations are randomly assigned to treatment or control group. This is the most common trial design for testing causality in health research.14
Regression discontinuity design Participants are assigned to treatment or control based on whether they fall above or below a criteria cutoff score. The assignment variable may be any variable measured before treatment. The design is similar to interrupted time series, but differs in that the effect or interruption occurs not at a specific time, but rather at a cutoff score in regression discontinuity. The design is most powerful when the cutoff is placed at the mean of the assignment variable since the analysis focuses on the subjects close to the cutoff score. Since only a fraction of the participants are used for the analysis, this technique requires more participants in otder to equal the power of a randomized experiment.
Stepped-wedge design1921 This design operates as a series of waiting lists and randomizes the order in which groups, locations or even populations receive the intervention. The intervention group can be compared with both their pretest measures and with measures from other subjects who have not yet received the treatment, who form an independent and homogeneous control group at each time point. In this design, all participants are told that they will receive intervention, which ensures participants are not denied intervention. Stepped-wedge design is appropriate if the intervention is going to be implemented with all individuals (or at all sites) and if it is not feasible to scale all at once.